ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,780Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 3001

$1.45M Total Retail Price of All Prescriptions

Rank: 39 out of 3001

1,032 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 1,032 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 1,032 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 24,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 980 898 1 1
HYDROCODONE-ACETAMINOPHEN 886 802 S3 2 7
FUROSEMIDE 866 791 3 6
OMEPRAZOLE 847 780 4 4
LISINOPRIL 756 697 5 2
LEVOTHYROXINE SODIUM 659 635 6 3
METOPROLOL TARTRATE 625 618 7 8
AMLODIPINE BESYLATE 623 589 8 5
POTASSIUM CHLORIDE 517 493 9 15
SERTRALINE HCL 468 427 10 20
METFORMIN HCL 426 395 11 9
CITALOPRAM HBR 404 387 12 16
GABAPENTIN 399 367 13 14
WARFARIN SODIUM 386 375 14 12
TRAZODONE HCL 383 331 15 37
TRAMADOL HCL 362 330 16 17
DONEPEZIL HCL 360 359 17 27
CLOPIDOGREL 355 333 18 28
RANITIDINE HCL 352 308 19 41
OXYCODONE-ACETAMINOPHEN 319 256 S2 20 32
LOSARTAN POTASSIUM 318 314 21 21
PLAVIX 310 292 22 46
METOPROLOL SUCCINATE 290 280 23 19
ATENOLOL 271 259 24 18
HYDROCHLOROTHIAZIDE 265 263 25 10
ROPINIROLE HCL 263 238 26 88
FENTANYL 226 219 S2 27 76
ISOSORBIDE MONONITRATE ER 222 221 28 45
TAMSULOSIN HCL 219 219 29 29
POLYETHYLENE GLYCOL 3350 217 198 30 55
ALENDRONATE SODIUM 205 187 31 26
CARVEDILOL 203 178 32 25
PRAVASTATIN SODIUM 197 197 33 13
NEXIUM 197 196 33 23
OXYCODONE HCL-ACETAMINOPHEN 181 148 S2 35 81
JANUVIA 174 172 36 54
PROAIR HFA 162 149 37 30
NAMENDA 156 156 38 40
CIPROFLOXACIN HCL 149 138 39 56
GLYBURIDE 146 135 R 40 62
CARBIDOPA-LEVODOPA 144 143 41 97
KLOR-CON M20 143 113 42 52
LOVASTATIN 137 127 43 38
CEPHALEXIN 131 118 44 86
BUPROPION HCL SR 126 126 45 190
DIOVAN 125 83 46 50
GLIMEPIRIDE 124 115 47 31
ZOLPIDEM TARTRATE 123 121 48 24
PREDNISONE 120 114 49 39
FLUTICASONE PROPIONATE 120 101 49 42
ALLOPURINOL 120 105 49 35
ADVAIR DISKUS 119 114 52 58
VENLAFAXINE HCL ER 118 78 53 103
OXYBUTYNIN CHLORIDE ER 117 94 54 79
AZITHROMYCIN 115 111 55 36
CYMBALTA 113 99 56 53
CRESTOR 111 111 57 33
KLOR-CON 10 109 107 58 160
OXYBUTYNIN CHLORIDE 106 93 59 120
LORAZEPAM 106 106 59 96
RAMIPRIL 104 96 61 114
ATORVASTATIN CALCIUM 103 102 62 11
FAMOTIDINE 103 101 62 68
PHENYTOIN SODIUM EXTENDED 101 87 64 126
MIRTAZAPINE 101 97 64 44
MORPHINE SULFATE ER 100 59 S2 66 150
DIVALPROEX SODIUM 97 89 67 70
LIDODERM 96 95 68 122
TERAZOSIN HCL 96 74 68 135
MELOXICAM 95 90 70 34
DILTIAZEM 24HR CD 92 88 71 124
LANTUS 91 85 72 47
QUETIAPINE FUMARATE 88 73 73 66
BACLOFEN 88 37 73 125
CELEBREX 87 85 75 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 69 76 22
LYRICA 82 79 76 87
RISPERIDONE 81 80 78 63
DIGOXIN 81 81 78 65
PAROXETINE HCL 79 67 80 60
FLUOXETINE HCL 79 44 80 61
FINASTERIDE 77 77 82 92
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 82 49
TRIAMTERENE-HCTZ 76 76 84 48
ESCITALOPRAM OXALATE 75 68 85 82
GLIPIZIDE 74 59 86 67
LEVOFLOXACIN 73 66 87 115
METHYLPREDNISOLONE 73 67 87 121
CLONIDINE HCL 73 67 87 64
KLOR-CON M10 72 70 90 138
VITAMIN D2 70 68 91 205
EVISTA 70 70 91 148
SPIRONOLACTONE 67 57 93 75
DILTIAZEM 24HR ER 64 64 94 131
SPIRIVA 63 63 95 57
MECLIZINE HCL 63 56 95 153
ACETAMINOPHEN-CODEINE 61 60 S3 97 141
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 55 98 77
PROMETHAZINE HCL 59 52 R 99 93
LANTUS SOLOSTAR 59 38 99 80
NYSTATIN 58 54 101 149
CLOTRIMAZOLE-BETAMETHASONE 58 51 101 181
SINGULAIR 58 50 101 95
EXELON 57 53 104 108
DIOVAN HCT 56 56 105 109
NOVOLOG 56 47 105 94
METFORMIN HCL ER 55 47 107 51
BUSPIRONE HCL 55 38 107 91
PROPYLTHIOURACIL 55 55 107 542
ALPRAZOLAM 53 53 110 98
TOPROL XL 53 53 110 229
NITROSTAT 52 51 112 270
TRICOR 51 45 113 132
VENLAFAXINE HCL 51 51 113 171
ZETIA 51 51 113 69
PANTOPRAZOLE SODIUM 51 51 113 43
AMITRIPTYLINE HCL 50 43 R 117 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.